Company intelligence / Profile preview

Progenika Biopharma

Derio, Bizkaia, Spain
Ownership
Private
Employees
~60
Development stage
Commercial
01

Overview

Progenika has developed and commercialized several CE-marked molecular diagnostic platforms. Notably, its NGS-based familial hypercholesterolemia test was the first approved NGS assay for this indication in Europe. Its blood group genotyping platform BLOODchip® has global distribution through Grifols and supports improved transfusion safety. The company also offers Promonitor® kits for therapeutic drug monitoring of biologics in autoimmune diseases[6].

Therapeutic areas
ImmunologyCardiovascularRare DiseasesHematology
Modalities
DNA biochips (DNA microarrays)Bead array-based assaysELISA tests
Industry
Molecular Diagnostics
02

Drug pipeline

2 assets

Promonitor QUICK

Registration
Indications
Immunological disorders

1 more asset in the full pipeline.

Request access →
03

Partnerships

Grifols – global distribution rights for BLOODchip since at least 2010; now parent company[5][8].

Beyond the preview

Go deeper on Progenika Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progenika Biopharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call